相似文献
1
Editorial: Current molecular, immunological, pathological and clinical aspects of pathogenic infections.
Front Cell Infect Microbiol. 2025 Aug 8;15:1665283. doi: 10.3389/fcimb.2025.1665283. eCollection 2025.
2
Epidemiological characteristics of Mycoplasma pneumoniae and viral infections in hospitalized children with recurrent lower respiratory tract infections.
Am J Transl Res. 2025 Jun 15;17(6):4341-4350. doi: 10.62347/RBTR5968. eCollection 2025.
3
Detection of Mycoplasma pneumoniae in hospitalized pediatric patients presenting with acute lower respiratory tract infections utilizing targeted next-generation sequencing.
Infection. 2025 Jan 31. doi: 10.1007/s15010-024-02467-8.
4
Analysis of epidemic trend of respiratory pathogens in children after long-term pathogen isolation.
PeerJ. 2025 Jul 16;13:e19710. doi: 10.7717/peerj.19710. eCollection 2025.
5
[Distribution of respiratory pathogens in patients with pneumonia in Yinzhou, Ningbo, 2015-2024].
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):496-506. doi: 10.19723/j.issn.1671-167X.2025.03.013.
6
[Infections with the human pathogenic Mycoplasma species M. genitalium and M. pneumoniae : Current epidemiological aspects].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 May 12. doi: 10.1007/s00103-025-04052-2.
7
The virome composition of respiratory tract changes in school-aged children with Mycoplasma pneumoniae infection.
Virol J. 2025 Jan 13;22(1):10. doi: 10.1186/s12985-025-02626-9.
8
Evolving clinical features of Mycoplasma pneumoniae infections following COVID-19 pandemic restrictions: a retrospective, comparative cohort study.
Eur J Pediatr. 2025 Aug 7;184(8):535. doi: 10.1007/s00431-025-06326-y.
9
Epidemiological association of the COVID-19 pandemic on infections in children in Tianjin, China: a single-centre retrospective study (2017-2024).
BMJ Open. 2025 Jun 17;15(6):e101045. doi: 10.1136/bmjopen-2025-101045.
10
The dynamics of common respiratory pathogens in southern china under the context of COVID-19 pandemic and prediction of mycoplasma pneumonia (2018-2023).
J Virol Methods. 2025 Dec;338:115240. doi: 10.1016/j.jviromet.2025.115240. Epub 2025 Aug 16.
本文引用的文献
1
COVID-19 management in patients with comorbid conditions.
World J Virol. 2025 Jun 25;14(2):102674. doi: 10.5501/wjv.v14.i2.102674.
2
Current Applications and the Future of Phage Therapy for Periprosthetic Joint Infections.
Antibiotics (Basel). 2025 Jun 6;14(6):581. doi: 10.3390/antibiotics14060581.
3
A systematic review of disease control strategies in beef cow-calf herds, part 2: preweaned calf morbidity and mortality associated with neonatal calf diarrhea and bovine respiratory disease.
Anim Health Res Rev. 2025 Mar 24;25:e1. doi: 10.1017/S1466252325000039.
4
The interaction of innate immune and adaptive immune system.
MedComm (2020). 2024 Sep 15;5(10):e714. doi: 10.1002/mco2.714. eCollection 2024 Oct.
5
Highlights of the 2023 American Joint Replacement Registry Annual Report.
Arthroplast Today. 2024 Feb 29;26:101325. doi: 10.1016/j.artd.2024.101325. eCollection 2024 Apr.
6
Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
Eur J Pediatr. 2024 Jul;183(7):3001-3011. doi: 10.1007/s00431-024-05519-1. Epub 2024 Apr 18.
7
The role of platelets in sepsis: A review.
Biomol Biomed. 2024 Jan 18;24(4):741-752. doi: 10.17305/bb.2023.10135.
8
Reducing the rate of central line-associated bloodstream infections; a quality improvement project.
BMC Infect Dis. 2023 Oct 30;23(1):745. doi: 10.1186/s12879-023-08744-5.
9
Mortality, patient-reported outcome measures, and the health economic burden of prosthetic joint infection.
EFORT Open Rev. 2023 Sep 1;8(9):690-697. doi: 10.1530/EOR-23-0078.
10
Bovine Airway Models: Approaches for Investigating Bovine Respiratory Disease.
ACS Infect Dis. 2023 Jun 9;9(6):1168-1179. doi: 10.1021/acsinfecdis.2c00618. Epub 2023 May 31.
Zotero 插件